Circulating endothelial cells in pathophysiology. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Current Opinion in Hematology Année : 2024

Circulating endothelial cells in pathophysiology.

Résumé

The purpose of this review is to synthesize recent insights into the roles and importance of circulating endothelial cells (CECs) as indicators of the severity, progression, and prognosis of vascular-related diseases. Recent studies have identified elevated counts of CECs in pathological conditions, notably inflammatory or cardiovascular diseases such as acute myocardial infarction and heart failure, underscoring their potential as sensitive indicators of disease. Furthermore, the rise in CEC levels in cancer patients, particularly with disease advancement, points to their role in cancer-associated angiogenesis and response to treatment. This review underscores the evolving significance of CECs as markers for evaluating the gravity and advancement of diseases with vascular injury, including cardiovascular diseases, cancer, inflammatory conditions, and thromboembolic events. These last years, efforts made to standardize flow cytometry detection of CEC and the development of highly sensitive techniques to isolate, quantify or phenotype rare cells open promising avenues for clinical application. This may yield extensive knowledge regarding the mechanisms by which endothelial cells contribute to a variety of vascular-related disorders and their clinical value as emerging biomarkers.
Fichier non déposé

Dates et versions

hal-04520469 , version 1 (25-03-2024)

Identifiants

Citer

Victor-Emmanuel Brett, Francoise Dignat-George, Chloe James. Circulating endothelial cells in pathophysiology.. Current Opinion in Hematology, 2024, 31 (3), pp.148-154. ⟨10.1097/MOH.0000000000000814⟩. ⟨hal-04520469⟩

Collections

CNRS U1034
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More